Abstract:Metabolically healthy obesity (MHO) accounts for roughly 35% of all obese patients. There is no clear consensus that has been reached on whether MHO is a stable condition or merely a transitory period between metabolically healthy lean and metabolically unhealthy obesity (MUO). Additionally, the mechanisms underlying MHO and any transition to MUO are not clear. Macrophages are the most common immune cells in adipose tissues and have a significant presence in atherosclerosis. Fas (or CD95), which is highly expressed on macrophages, is classically recognized as a pro-apoptotic cell surface receptor. However, Fas also plays a significant role as a pro-inflammatory molecule. Previously, we established a mouse model (ApoE(-/-)/miR155(-/-); DKO mouse) of MHO, based on the criteria of not having metabolic syndrome (MetS) and insulin resistance (IR). In our current study, we hypothesized that MHO is a transition phase toward MUO, and that inflammation driven by our newly classified CD95(+)CD86(-) macrophages is a novel mechanism for this transition. We found that, with extended (24 weeks) high-fat diet feeding (HFD), MHO mice became MUO, shown by increased atherosclerosis. Mechanistically, we found the following: 1) at the MHO stage, DKO mice exhibited increased pro-inflammatory markers in adipose tissue, including CD95, and serum; 2) total adipose tissue macrophages (ATMs) increased; 3) CD95(+)CD86(-) subset of ATMs also increased; and 4) human aortic endothelial cells (HAECs) were activated (as determined by upregulated ICAM1 expression) when incubated with conditioned media from CD95(+)-containing DKO ATMs and human peripheral blood mononuclear cells-derived macrophages in comparison to respective controls. These results suggest that extended HFD in MHO mice promotes vascular inflammation and atherosclerosis via increasing CD95(+) pro-inflammatory ATMs. In conclusion, we have identified a novel molecular mechanism underlying MHO transition to MUO with HFD. We have also found a previously unappreciated role of CD95(+) macrophages as a potentially novel subset that may be utilized to assess pro-inflammatory characteristics of macrophages, specifically in adipose tissue in the absence of pro-inflammatory miR-155. These findings have provided novel insights on MHO transition to MUO and new therapeutic targets for the future treatment of MUO, MetS, other obese diseases, and type II diabetes.

Abstract 371: Deficiency in Microrna-155 Leads to Reduced Atherosclerosis, Increased Obesity and Nonalcoholic Fatty Liver Disease--A Novel Mouse Model of Metabolically Healthy Obesity

Microrna-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-Alcoholic Fatty Liver Disease A Novel Mouse Model of Obesity Paradox

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

A Novel Subset of CD95+ Pro-Inflammatory Macrophages Overcome miR155 Deficiency and May Serve as a Switch From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity

A Novel Subset of CD95<SUP>+</SUP> Pro-Inflammatory Macrophages Overcome miR155 Deficiency and May Serve as a Switch From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity

miR-155 Deletion in Female Mice Prevents Diet-Induced Obesity

miR155 deficiency aggravates high-fat diet-induced adipose tissue fibrosis in male mice

Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH

Differential Expression of Micrornas in Mouse Liver under Aberrant Energy Metabolic Status

Metagenomic and metabolomic analyses show correlations between intestinal microbiome diversity and microbiome metabolites in ob/ob and ApoE-/- mice

Impact of Mir‐140 Deficiency on Non‐Alcoholic Fatty Liver Disease

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

An accelerated mouse model for atherosclerosis and adipose tissue inflammation

Adipocyte-derived Microvesicles from Obese Mice Induce M1 Macrophage Phenotype Through Secreted Mir-155.

Loss of Microrna-22 Prevents High-Fat Diet Induced Dyslipidemia and Increases Energy Expenditure Without Affecting Cardiac Hypertrophy

Adipocyte Mir-200B/a/429 Ablation in Mice Leads to High-Fat-diet-induced Obesity.

Abstract 13320: APOO Knockout Elevates Plasma Cholesterol Levels Independent of LDLR and Accelerates Atherosclerosis in Mice

Abstract 943: Circulating Mirnome in Obese and Lean Heart Failure Patients: A Case-control Study

Overexpression of Mir-155 in the Liver of Transgenic Mice Alters the Expression Profiling of Hepatic Genes Associated with Lipid Metabolism.

Deep Sequencing of Small RNA Repertoires in Mice Reveals Metabolic Disorders-Associated Hepatic Mirnas.

Gain of Metabolic Benefit with Ablation of Mir-149-3p from Subcutaneous Adipose Tissue in Diet-Induced Obese Mice